Victory Capital Management Inc Biomarin Pharmaceutical Inc Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

A detailed history of Victory Capital Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 101,225 shares of BMRN stock, worth $6.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
101,225
Previous 101,200 0.02%
Holding current value
$6.8 Million
Previous $8.33 Million 14.6%
% of portfolio
0.01%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$69.02 - $93.84 $1,725 - $2,346
25 Added 0.02%
101,225 $7.12 Million
Q2 2024

Aug 05, 2024
BUY
$74.43 - $92.22 $985,006 - $1.22 Million
13,234 Added 15.04%
101,200 $8.33 Million
Q1 2024

May 03, 2024
SELL
$83.81 - $99.0 $972,866 - $1.15 Million
-11,608 Reduced 11.66%
87,966 $7.68 Million
Q4 2023

Feb 05, 2024
SELL
$76.22 - $98.51 $1.57 Million - $2.03 Million
-20,646 Reduced 17.17%
99,574 $9.6 Million
Q3 2023

Nov 06, 2023
BUY
$85.07 - $94.48 $735,430 - $816,779
8,645 Added 7.75%
120,220 $10.6 Million
Q2 2023

Jul 27, 2023
SELL
$86.68 - $100.3 $3.58 Million - $4.14 Million
-41,321 Reduced 27.03%
111,575 $9.67 Million
Q1 2023

May 02, 2023
BUY
$87.74 - $117.27 $2 Million - $2.67 Million
22,796 Added 17.52%
152,896 $14.9 Million
Q4 2022

Apr 25, 2023
SELL
$80.93 - $108.63 $50.6 Million - $67.9 Million
-625,225 Reduced 82.78%
130,100 $13.5 Million
Q4 2022

Feb 10, 2023
BUY
$80.93 - $108.63 $1.2 Million - $1.61 Million
14,809 Added 2.0%
755,325 $78.2 Million
Q4 2022

Feb 09, 2023
BUY
$80.93 - $108.63 $408,372 - $548,146
5,046 Added 0.69%
740,516 $76.6 Million
Q3 2022

Nov 02, 2022
BUY
$82.16 - $96.94 $1.94 Million - $2.29 Million
23,652 Added 3.32%
735,470 $62.3 Million
Q2 2022

Aug 01, 2022
SELL
$71.48 - $86.85 $107,077 - $130,101
-1,498 Reduced 0.21%
711,818 $59 Million
Q1 2022

May 04, 2022
SELL
$74.28 - $92.69 $1.72 Million - $2.15 Million
-23,155 Reduced 3.14%
713,316 $58 Million
Q4 2021

Feb 07, 2022
BUY
$71.72 - $91.47 $5,952 - $7,592
83 Added 0.01%
736,471 $65.1 Million
Q3 2021

Nov 02, 2021
BUY
$74.77 - $85.47 $1.49 Million - $1.7 Million
19,903 Added 2.78%
736,388 $56.9 Million
Q2 2021

Aug 03, 2021
SELL
$75.51 - $84.79 $82,834 - $93,014
-1,097 Reduced 0.15%
716,485 $59.8 Million
Q1 2021

May 04, 2021
SELL
$74.73 - $90.69 $2.08 Million - $2.53 Million
-27,874 Reduced 3.74%
717,582 $54.2 Million
Q4 2020

Feb 01, 2021
SELL
$72.61 - $90.2 $1.8 Million - $2.24 Million
-24,817 Reduced 3.22%
745,456 $65.4 Million
Q3 2020

Nov 09, 2020
BUY
$71.87 - $131.03 $1.62 Million - $2.95 Million
22,534 Added 3.01%
770,273 $58.6 Million
Q2 2020

Aug 07, 2020
BUY
$79.55 - $124.22 $49.7 Million - $77.6 Million
624,406 Added 506.28%
747,739 $92.2 Million
Q1 2020

May 04, 2020
BUY
$71.37 - $96.85 $228,098 - $309,532
3,196 Added 2.66%
123,333 $10.4 Million
Q4 2019

Feb 06, 2020
BUY
$64.27 - $86.37 $131,560 - $176,799
2,047 Added 1.73%
120,137 $10.2 Million
Q4 2019

Feb 04, 2020
BUY
$64.27 - $86.37 $110,287 - $148,210
1,716 Added 1.47%
118,090 $9.86 Million
Q3 2019

Nov 12, 2019
SELL
$67.4 - $85.11 $5.08 Million - $6.41 Million
-75,316 Reduced 39.29%
116,374 $7.84 Million
Q2 2019

Aug 15, 2019
SELL
$80.35 - $93.9 $15.4 Million - $18 Million
-192,105 Reduced 50.05%
191,690 $16.4 Million
Q1 2019

May 03, 2019
SELL
$84.2 - $98.62 $12.9 Million - $15.1 Million
-152,785 Reduced 28.47%
383,795 $34.1 Million
Q4 2018

Feb 05, 2019
SELL
$80.14 - $106.07 $4.02 Million - $5.32 Million
-50,158 Reduced 8.55%
536,580 $45.7 Million
Q3 2018

Nov 01, 2018
SELL
$93.92 - $105.72 $9.22 Million - $10.4 Million
-98,197 Reduced 14.34%
586,738 $56.9 Million
Q2 2018

Aug 02, 2018
SELL
$76.01 - $99.03 $5.1 Million - $6.64 Million
-67,070 Reduced 8.92%
684,935 $64.5 Million
Q1 2018

May 04, 2018
SELL
$77.67 - $92.63 $2.75 Million - $3.28 Million
-35,450 Reduced 4.5%
752,005 $61 Million
Q4 2017

Feb 01, 2018
SELL
$80.76 - $95.13 $5.46 Million - $6.43 Million
-67,592 Reduced 7.91%
787,455 $70.2 Million
Q3 2017

Oct 27, 2017
SELL
$80.6 - $94.95 $150,560 - $177,366
-1,868 Reduced 0.22%
855,047 $79.6 Million
Q2 2017

Aug 07, 2017
BUY
N/A
856,915
856,915 $77.8 Million

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email